US2387244A - Tablet and method of dissolving same - Google Patents
Tablet and method of dissolving same Download PDFInfo
- Publication number
- US2387244A US2387244A US447706A US44770642A US2387244A US 2387244 A US2387244 A US 2387244A US 447706 A US447706 A US 447706A US 44770642 A US44770642 A US 44770642A US 2387244 A US2387244 A US 2387244A
- Authority
- US
- United States
- Prior art keywords
- tablet
- solution
- acid
- dissolution
- heat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title description 4
- 239000003826 tablet Substances 0.000 description 105
- 239000000243 solution Substances 0.000 description 40
- 238000012360 testing method Methods 0.000 description 35
- 239000004615 ingredient Substances 0.000 description 31
- 239000007788 liquid Substances 0.000 description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- 238000004090 dissolution Methods 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 239000002253 acid Substances 0.000 description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 239000000463 material Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 235000000346 sugar Nutrition 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 229910052783 alkali metal Inorganic materials 0.000 description 9
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 8
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 7
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 7
- 239000003513 alkali Substances 0.000 description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 description 7
- 235000015165 citric acid Nutrition 0.000 description 7
- 230000008021 deposition Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 7
- 235000002906 tartaric acid Nutrition 0.000 description 7
- 210000002700 urine Anatomy 0.000 description 7
- 230000002378 acidificating effect Effects 0.000 description 6
- 150000001340 alkali metals Chemical class 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 239000001569 carbon dioxide Substances 0.000 description 6
- 239000003518 caustics Substances 0.000 description 6
- 230000002452 interceptive effect Effects 0.000 description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 5
- -1 sodium acid sulfate Chemical class 0.000 description 5
- 239000011973 solid acid Substances 0.000 description 5
- 239000011975 tartaric acid Substances 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 229940071207 sesquicarbonate Drugs 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- BERDEBHAJNAUOM-UHFFFAOYSA-N copper(I) oxide Inorganic materials [Cu]O[Cu] BERDEBHAJNAUOM-UHFFFAOYSA-N 0.000 description 3
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 3
- KRFJLUBVMFXRPN-UHFFFAOYSA-N cuprous oxide Chemical compound [O-2].[Cu+].[Cu+] KRFJLUBVMFXRPN-UHFFFAOYSA-N 0.000 description 3
- 229940112669 cuprous oxide Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 239000005749 Copper compound Substances 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 150000001860 citric acid derivatives Chemical class 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 150000001880 copper compounds Chemical class 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 230000003113 alkalizing effect Effects 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- HODFCFXCOMKRCG-UHFFFAOYSA-N bitolterol mesylate Chemical compound CS([O-])(=O)=O.C1=CC(C)=CC=C1C(=O)OC1=CC=C(C(O)C[NH2+]C(C)(C)C)C=C1OC(=O)C1=CC=C(C)C=C1 HODFCFXCOMKRCG-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- QLHZECDNPPYKFB-UHFFFAOYSA-L potassium sodium hydrogen carbonate hydrogen sulfate Chemical compound [Na+].[K+].OC(O)=O.[O-]S([O-])(=O)=O QLHZECDNPPYKFB-UHFFFAOYSA-L 0.000 description 1
- GZYHNIHHRYGVCV-UHFFFAOYSA-M potassium;hydrogen carbonate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [K+].OC(O)=O.OC(=O)CC(O)(C(O)=O)CC([O-])=O GZYHNIHHRYGVCV-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 description 1
- 235000018341 sodium sesquicarbonate Nutrition 0.000 description 1
- 239000007944 soluble tablet Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose
Definitions
- This invention relates to an improvement in tablet compositions to be dissolved in water or aqueous liquids to introduce active ingredients,
- such as testing agents in particular, it relates to such tablets in which the hydroxides of the alkali metals are among the necessary ingredients. It relates particularly to analytical compositions in tablet form which are designed to dissolve directly in water solutions and, while so dissolving, provide the proper analytical reagents with possibly other necessary conditions such as alkalinity, or heat by heat of solution and/or by heat of reaction, for the indications of the presence or absence of, or the quantitative estimation of, a substance or group of substances in the original water solution, such as sugar in urine. While these analytical tablets will dissolve with little or no dimculty in some water solutions, many other water solutions contain ingredients which inhibit or prevent their solution.
- the mechanism of the inhibitive action of these ingredients is their deposition upon the tablets in the form of an insoluble coating which thereby effectively retards or prevents free access of the water to the tablet.
- a tablet containing an alkali-metal hydroxide When a tablet containing an alkali-metal hydroxide is placed into a solution containing such interfering ingredients, the heat evolved and/or the alkalinity of the resulting solution tends to deposit a precipitate or coagulum upon the surface of the tablet. Such deposit may encapsulate the tablet with a. water excluding film, Manifestly, the purpose of the tablet may under such circumstances be defeated.
- These interfering substances are defined as thosesubstances which, inthe presence of heat and/or alkalinity, are precipitated or coagulated from their original dissolved or suspended state.
- Substances of this nature are common constituents of such fluids as urine, cerebrospinal fluid, blood, ascitic fluid, and various other body transudates and exudates, milk, beer, etc., which are representative of the types of solutions in which analytical tablets are designed to be employed.
- an improved analytical tablet made according to the present invention will contain, in addition to its analytical reagents, an effervescent couple comprising a solid soluble acidic substance such as citric acid, the alkali metal acid citrates, tartaric acid, or the alkali metal bisulfates and a carbonate such as the alkali-metal normal carbonates, sesquicarbonates or bicarbonates, chosen so that none of the ingredients or their reaction products will be nc mpatible with the purpose of the test, or the balance of the reagents.
- an effervescent couple comprising a solid soluble acidic substance such as citric acid, the alkali metal acid citrates, tartaric acid, or the alkali metal bisulfates and a carbonate such as the alkali-metal normal carbonates, sesquicarbonates or bicarbonates, chosen so that none of the ingredients or their reaction products will be nc mpatible with the purpose of the test, or the balance of the reagents.
- the acid reacts with the normal carbonate, sesquicarbonate, or bicarbonate, liberating C02, at and below the surface of the tablet.
- This escaping gas prevents the gummy precipitate or coagulum from forming an envelope on the surface of the tablet, and also tends V to disintegrate the tablet.
- the escaping gas creates agitation of the solution and causes mobility of the dissolving tablet in the solution, whereby fresh liquid is constantly brought to the undissolved residue of the tablet to hasten its solution. Hence, continued access of the water to the tablet is permitted, and the reaction proceeds more rapidly to completion than when no effervescent couple is used.
- a further advantage was found in that the tendency of eifervescence to break up the tablet and constantly to bring fresh tablet surface in contact with the water materially speeds the solution of the tablet, and thus produces a, more rapid rise in temperature, which in many such tests is an advantage.
- the invention specifically is directed to the solution of analytical tablets which contain as one component a substance which is essential to the contemplated test, but which, if not properly controlled, would render solution very dimcult, if not impossible.
- an analytical tablet containing sodium hydroxide as an essential component will be retarded or even prevented in a urine containing albumin, since the latter will tend to precipitate on the tablet as a water excluding or water-impervious envelope.
- Formula I represents a typical composition employed for the detection of reducing sugars in water solutions.
- Formula II represents a typical composition used for the detection of acetone in water solutions.
- Citric acid Citric acid
- CGHaOl 9 Cupric sulfate CuS04 4. 1 Sodium hydroxide, NaOH 16 Effervescent couple composed of- (a) Citric acid, CGHBOI 4 Sodium bicarbonate, NaHCOa 4 I (b) Tartaric acid, Cd-hoe 6 Sodium carbonate, Na:CO.-4 2.5
- potassium hydroxide or other alkali metal hyroxides may be used.
- compositions of Formula I employ the caustic alkali for its high heat of solution and for its heat of reaction with the acid ingredient as well as for alkalinity.
- the caustic alkali when such a composition is added to a solution of a reducing sugar, the caustic alkali, by its heat of solution and the heat of its reaction with the acidic component, provides the proper temperature for the reduction of the cupric ions by the sugar. At the same time, a high degree of alkalinity is maintained in the solution.
- caustic alkali in Formula II The purpose of the caustic alkali in Formula II is primarily to provide the proper heat and alkalinity for the test.
- the caustic alkali content of the tablet is proportioned to the amount of fluid under test and the type of test.
- a tablet containing 0.3 gram of sodium hydroxide is added to approximately 0.5 cc. of urine.
- a carbonate is intended generically to include the normal carbonate, a sesquicarbonate, and bicarbonate each alone or in admixture.
- a normally self-sustaining heat-generating compressed sugar-testing tablet comprising homogeneously mixed dry powdery materials including a quantity of anhydrous alkali metal hydroxide in quantity in excess of that reactive with all the remaining ingredients of the tablet and in quantity to generate heat for effecting the test, anhydrous cupric sulfate, acid for the sugar test selected from the group consistin of citric and tartaric acids, and an effervescent couple consisting of acid selected from the group consisting of citric and tartaric acids and of carbonate salt selected from the group consisting of alkali metal carbonate and alkali metal bicarbonate, said tablet being adapted to be placed in a liquid specimen to be tested for reducing sugar, which specimen may contain an ingredient tending to deposit upon and retard dissolution of the tablet, said couple functioning to generate gas and break up the tablet while the material of the tablet is dissolving in said liquid specimen and is raising the temperature of said specimen to efiect said test by forming cuprous oxide, the generation of gas avoiding exercise of any tendency of any ingredient of the
- a normally self-sustaining heat-generating compressed sugar-testing tablet comprising homogeneously mixed dry powdery materials including a quantity of anhydrous alkali metal hydroxide in quantity in excess of that reactive with all the remaining ingredients of the tablet and in quantity to generate heat for effectin the test,
- water-soluble cupric salt acidic material neutralizable by a portion of said hydroxide to form upon dissolution of the tablet a dissolved reducible cupric compound
- an effervescent couple consisting of water-soluble solid acid and of watersoluble salt of carbonic acid
- said tablet being adapted to be placed in a liquid specimen to be tested for reducing sugar, which specimen may contain an ingredient tending to deposit upon and retard dissolution of the tablet, said couple functioning to generate gas and break up the tablet while the material of the tablet is dissolving in said liquid specimen and is raising the temperature of said specimen to effect said test by forming cuprous oxide, the generation of gas avoiding exercise of any tendency of any ingredient of the specimen to deposit upon any mass of the tablet and retard its dissolution, whereby the dissolution is hastened and the attained temperature is higher by avoiding loss of heat through shorter time for dissolution.
- a normally self-sustaining heat-generating compressed sugar-testing tablet comprising homogeneously mixed dry powdery materials including a quantity of anhydrous alkali metal hydroxide in quantity in excess of that reactive with all the remaining ingredients of the tablet and in quantity to generate heat for effecting the test, watersoluble cupric salt, solubilizing agent selected from the group consisting of tartaric acid, citric acid, and their alkali metal salts for dissolving the reaction product of said cupric salt and said alkali metal hydroxide for supplying to the specimen a dissolved reducible cupric compound, and an effervescent couple consisting of water-soluble solid acid and of water-soluble salt of carbonic acid, said tablet being adapted to be placed in a liquid specimen to be tested for reducing sugar, which specimen may contain an ingredient tending to deposit upon and retard dissolution of the tablet, said couple functioning to generate gas and break up the tablet while the material of the tablet is dissolving in said liquid specimen and is raising the temperature of said specimen to eifect said test by forming cuprous oxide, the
- a testing tablet adapted for dissolution in an aqueous liquid to be tested, which liquid may contain an ingredient tending to retard the dissolution of the tablet by deposition thereon, and adapted to supply chemical reagent material to eflect the test, said tablet comprising dry solid ingredients in uniform distribution, including a quantity of alkali metal hydroxide which is effective in the test upon dissolution of the tablet in the liquid, and further comprising an efiervescent couple consisting of solid acid and of solid salt of carbonic acid for interaction in the presence of water to generate carbon dioxide'on contact with said liquid for breaking up the tablet, the quantity of said hydroxide being greater than that which is chemically equivalent to the active acid content of said couple, whereby said carbon dioxide is formed in the presence of undissolved hydroxide to break up the tablet and hasten its dissolution, the generation of gas being also effective to agitate the liquid and to expose fresh tablet surfaces with the avoidance of possible dissolution-retarding deposition on any solid mass of the original tablet form.
- a testing tablet adapted for dissolution in an aqueous liquid to be tested, which liquid may contain an ingredient tending to retard the dissolution of the tablet by deposition thereon, said tablet comprising dry solid ingredients in uniform distribution, including chemical reagent material to effect the test, and further comprising alkali metal hydroxide and also an effervescent couple consisting of solid acid and of solid salt of carbonic acid for interaction in the presence of water to generate carbon dioxide on contact with said liquid for breaking up the tablet, the amount of said hydroxide in the tablet bein in excess of an amount which will neutralize the acid of the said couple, whereby said carbon dioxide is formed in the presence of undissolved ingredients of the tablet to break up the tablet and hasten its dissolution, the generation of gas being also effective to agitate the liquid and to expose fresh tablet 45 surfaces with the avoidance of possible dissolution-retarding deposition on any solid mass of the original tablet form,
- the step of dissolving in said liquid specimen a tablet containing in homogeneous admixture chemical reagent material for the test including an alkalizing quantity of alkali metal hydroxide, and an efiervescent couple consisting of watersoluble solid acid and water-soluble salt of carbonic acid, the amount of said hydroxide in the tablet being in excess of an amount which will neutralize the acid of the said couple, while generating carbon dioxide in the tablet in the presence of said hydroxide, and thereby breaking up the tablet and exposing fresh surfaces thereof, with the result of avoiding the exercise of any tendency of an ingredient of said specimen to retard the dissolution of the tablet.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
e or prssonvma *1 so 1 Walter A. Compton and Joseph M. Treneer, Elk= hart, Ind, assignors to Miles Laboratories, Kna, Elkhart, llnd., a corporation of Indiana N Drawing. Application June 19, 1942, Serial No. 447,706
'7 Claims.
This invention relates to an improvement in tablet compositions to be dissolved in water or aqueous liquids to introduce active ingredients,
such as testing agents. In particular, it relates to such tablets in which the hydroxides of the alkali metals are among the necessary ingredients. It relates particularly to analytical compositions in tablet form which are designed to dissolve directly in water solutions and, while so dissolving, provide the proper analytical reagents with possibly other necessary conditions such as alkalinity, or heat by heat of solution and/or by heat of reaction, for the indications of the presence or absence of, or the quantitative estimation of, a substance or group of substances in the original water solution, such as sugar in urine. While these analytical tablets will dissolve with little or no dimculty in some water solutions, many other water solutions contain ingredients which inhibit or prevent their solution. The mechanism of the inhibitive action of these ingredients is their deposition upon the tablets in the form of an insoluble coating which thereby effectively retards or prevents free access of the water to the tablet. When a tablet containing an alkali-metal hydroxide is placed into a solution containing such interfering ingredients, the heat evolved and/or the alkalinity of the resulting solution tends to deposit a precipitate or coagulum upon the surface of the tablet. Such deposit may encapsulate the tablet with a. water excluding film, Manifestly, the purpose of the tablet may under such circumstances be defeated. These interfering substances are defined as thosesubstances which, inthe presence of heat and/or alkalinity, are precipitated or coagulated from their original dissolved or suspended state. Substances of this nature are common constituents of such fluids as urine, cerebrospinal fluid, blood, ascitic fluid, and various other body transudates and exudates, milk, beer, etc., which are representative of the types of solutions in which analytical tablets are designed to be employed.
Specific examples of substances which interfere with solution of these tablets are albumin, mucin, and the phosphates, and other complex organic or inorganic substances whose chemical formulae are not necessarily known, and need not be defined for the purpose of applying this invention provided they satisfy the definition above regarding precipitation or coagulation by heat and/or alkalinity. The present invention is not, of course, limited in its application only to the above fluids, or to the specifically cited interfering substances, but is intended for use in connection with all water solutions containing dissolved or suspended ingredients which are precipitated or congealed by heat or alkalinity or both.
That the dimculty in dissolving such tablets in the types of solution illustrated above is due to the formation of an insoluble envelope or sheath around the tablet can be demonstrated by placingthe tablet in such a solution, and when it has failed to complete its reaction, removing it and then placing it in water. It will then fail to react or react at best sluggishly, whereas a fresh tablet of identical nature (or the same tablet broken in half so as to present a clean surface) placed in water will react briskly and completely. That the interfering substances will form such an impervious envelope or sheath around the tablet and not simply be thrown into general suspension in the liquid, where they would not interfere, is reasonable, since when the tablet is first dropped into the solution, the alkali and heat will be most concentrated in and around the. surface of the tablet. Where the action of a tablet is impeded by film formation, it may be remedied by repeatedly breaking up the undissolved residue of the tablet. lSuch remedy is impractical, and is avoided by the present invention.
It was further found that the dificulty could be prevented by first making the solution alkaline and/or hot which would throw down the precipitate or coagulum before the tablet was added and so allow the tablet to react with the balance of the water and dissolved ingredients. This, however, involved the use of an additional reagent and/or heat in the carrying out of the test, and is hence undesirable since the chief advantage gained in employing the type oftablet described above is that only one operation is necessary to carry out the test, namely, to add a tablet to the solution tobe tested.
In seeking to circumvent these difdculties it was found that if the tablet could be made to disintegrate promptly upon being introduced into the solution the much more violent reaction so produced would prevent the encapsulation from occurring, since the reaction would thus become sufficiently violent to dislodge any such precipitate or coagulum.
Among the methods tried to defeat this dimculty was the addition to the tablet oi. anhydrous or dehydrated starch which is commonly used in tablet making to provide disintegration of an otherwise very slowly soluble or difflcultly soluble tablet in water or watery solutions. The heat of reaction of a preparation of this type, however,
is sufilciently great to cause the starch to jell, I and so defeat the purpose for which it was added.
After considerable experimentation, it was found that the incorporation into the tablet of a. soluble solid acidic substance not incompatible with the purposes of the test or-with the other ingredients, such as for example citric acid, alkali metal acid citrates, tartaric acid or alkali metal acid sulfates such as sodium acid sulfate, or potassium acid sulfate, together with a normal carbonate, sesquicarbonate or bicarbonate, also not incompatible with the purposes of the test or with the other ingredients, such as for example sodium I carbonate, sodium sesquicarbonate, or sodium bicarbonate, would solve the diillculty. In other I words, the most efiective method by which to accomplish the desired end was found to be efl'ervescent disintegration. Accordingly, an improved analytical tablet made according to the present invention will contain, in addition to its analytical reagents, an effervescent couple comprising a solid soluble acidic substance such as citric acid, the alkali metal acid citrates, tartaric acid, or the alkali metal bisulfates and a carbonate such as the alkali-metal normal carbonates, sesquicarbonates or bicarbonates, chosen so that none of the ingredients or their reaction products will be nc mpatible with the purpose of the test, or the balance of the reagents.
On placing the tablet containing these additional ingredients in water, the acid reacts with the normal carbonate, sesquicarbonate, or bicarbonate, liberating C02, at and below the surface of the tablet. This escaping gas prevents the gummy precipitate or coagulum from forming an envelope on the surface of the tablet, and also tends V to disintegrate the tablet. The escaping gas creates agitation of the solution and causes mobility of the dissolving tablet in the solution, whereby fresh liquid is constantly brought to the undissolved residue of the tablet to hasten its solution. Hence, continued access of the water to the tablet is permitted, and the reaction proceeds more rapidly to completion than when no effervescent couple is used. A further advantage was found in that the tendency of eifervescence to break up the tablet and constantly to bring fresh tablet surface in contact with the water materially speeds the solution of the tablet, and thus produces a, more rapid rise in temperature, which in many such tests is an advantage. In the practice of. a specific embodiment of our invention, 1. e. in the use of a carbon-dioxide generating efiervescent couple, which couple is compatible with the test, in a tablet supplying sodium hydroxide and a reducible copper compound for detecting the presence of reducing sugar in urine or similar fluids, it was found that a more rapid generation of heat was attained. This is of great practical advantage, since it insures under all conditions that one may expect to encounter, the attainment of the necessary temperature required for complete reaction of all the available reducing sugar with the copper compound. By more quickly efl'ecting complete dissolution, less heat is lost by exposure, and hence in fact a higher final temperature is possible. This advantage is additional to the principal advantage of the invention.
We are aware that effervescent couples have been employed heretofore in tableted compositions to hasten their disintegration and solution. Therefore, we make no claim to such matter broadly. The invention specifically is directed to the solution of analytical tablets which contain as one component a substance which is essential to the contemplated test, but which, if not properly controlled, would render solution very dimcult, if not impossible. Thus, the solution of an analytical tablet containing sodium hydroxide as an essential component will be retarded or even prevented in a urine containing albumin, since the latter will tend to precipitate on the tablet as a water excluding or water-impervious envelope. By the method of the present invent on,
however, such analytical compositions are ren-. dered readily soluble, since the eflervescent action prevents the formation by coagulation of a film of the solution inhibiting ingredients upon the tablet. It is seen, then, that ourmethod for obtaining the solution of an analytical tablet is applicable to all cas s where an undesirable reaction between one of the essential components of the tablet and an interfering ingredient of the solution to be tested would tend to prevent solution by enveloping the tablet by a water-impervious film.
While it might, in the light of our disclosure, appear obvious to utilize the mechanism of offervescence to secure the desirable effect of our invention, abstract consideration of the problem will show that such was not the case. In all analytical tablets of the type with which. we have experimented, caustic alkali is present in preponderant quantity, generally in large excess of the amount required to neutralize all acidic components. The carbonate component is present in only small amount. It was questioned, therefore, whether such a composition could be made to eflervesce while maintaining therein only the usual small quantity of the effervescent couple, in view of the large amount of caustic alkali available to neutralize the acid component of the couple or even to react with the bicarbonate portion of the couple where bicarbonate is to be used. It was also thought that substantial efiervescence could not be expected in the attendant highly alkaline solution;
The presence of carbonates in the final solution after reaction has ceased, does not necessarily indicate that the acid andnormal carbonate, sesquicarbonate or bicarbonate have not reacted, and 50 carried out the purpose above described, since CO: in escaping through a strongly alkaline solution, such as would be produced by these tablets, would naturally be absorbed at least in part, depending upon the opportunity for dissolving contact.
By experimentation, however, it was demonstrated that this combination is operative.
The following examples illustrate'the use of an effervescent couple in an analytical tablet, such as is adverted to above. Formula I represents a typical composition employed for the detection of reducing sugars in water solutions. Formula II represents a typical composition used for the detection of acetone in water solutions. These formulae are merely illustrative of compositions prepared in accordance with our invention and are not to be considered in a limiting sense. Other modifications will occur to anyone skilled in the art. Y
Formula I Parts Citric acid, CGHaOl 9 Cupric sulfate, CuS04 4. 1 Sodium hydroxide, NaOH 16 Effervescent couple composed of- (a) Citric acid, CGHBOI 4 Sodium bicarbonate, NaHCOa 4 I (b) Tartaric acid, Cd-hoe 6 Sodium carbonate, Na:CO.-4 2.5
assua e For the sodium hydroxide in the above formula.
potassium hydroxide or other alkali metal hyroxides may be used.
For the effervescent couple above recited other couples, such as sodium bisulfate-potassium carbonate, citric acid-potassium bicarbonate, sodium acid citrate-lithium carbonate, etc., may be substituted. Many effervescent couples are known, and are not here claimed per so. It is to be observed that the ingredients of the tablet are in all cases to be chosen to be compatible with each other and for the purpose of the particular test to be performed by the use of the tablet.
Formula II Parts by weight Salicylaldehyde sodium bisulfite,
C'IHsOaNEHSO3 1 Tartaric acid, C4Hs06 15 Sodium carbonate, NazCO: 2.5
Sodium hydroxide, NaOH 16 The compositions of Formula I employ the caustic alkali for its high heat of solution and for its heat of reaction with the acid ingredient as well as for alkalinity. For example, when such a composition is added to a solution of a reducing sugar, the caustic alkali, by its heat of solution and the heat of its reaction with the acidic component, provides the proper temperature for the reduction of the cupric ions by the sugar. At the same time, a high degree of alkalinity is maintained in the solution.
The purpose of the caustic alkali in Formula II is primarily to provide the proper heat and alkalinity for the test.
In any case, however, solution of a tablet of these compositions will be greatly retarded, or rendered altogether impossible, by the presence of interfering substances in the solution to be tested, unless an effervescent couple is incorporated in the tablet.
It is to be understood that the caustic alkali content of the tablet is proportioned to the amount of fluid under test and the type of test.
For example, in testing urine for the presence of reducing sugar, a tablet containing 0.3 gram of sodium hydroxide is added to approximately 0.5 cc. of urine.
It may be observed that acid in proportion greater than is necessary for the effervescent coupie is present in Formula I. The. heat of reaction between the said excess of acid and the hydroxide yields heat which in addition to the heat of solution is useful in making a test for the presence of reducing sugar in urine. It is also be observed that in Formula I the acidic element of the couple is chosen to exert a function in the testitself, in that it forms a complex with the cupric ion, useful in the test.
In the specification and claims, the term a carbonate is intended generically to include the normal carbonate, a sesquicarbonate, and bicarbonate each alone or in admixture.
Having described our invention, what we claim and wish to protect by Letters Patent is:
1. A normally self-sustaining heat-generating compressed sugar-testing tablet comprising homogeneously mixed dry powdery materials including a quantity of anhydrous alkali metal hydroxide in quantity in excess of that reactive with all the remaining ingredients of the tablet and in quantity to generate heat for effecting the test, anhydrous cupric sulfate, acid for the sugar test selected from the group consistin of citric and tartaric acids, and an effervescent couple consisting of acid selected from the group consisting of citric and tartaric acids and of carbonate salt selected from the group consisting of alkali metal carbonate and alkali metal bicarbonate, said tablet being adapted to be placed in a liquid specimen to be tested for reducing sugar, which specimen may contain an ingredient tending to deposit upon and retard dissolution of the tablet, said couple functioning to generate gas and break up the tablet while the material of the tablet is dissolving in said liquid specimen and is raising the temperature of said specimen to efiect said test by forming cuprous oxide, the generation of gas avoiding exercise of any tendency of any ingredient of the specimen to deposit upon any mass of the tablet and retard its dissolution, whereby the dissolution is hastened and the attained temperature is higher by avoiding loss of heat through shorter time for dissolution.
2. A normally self-sustaining heat-generating compressed sugar-testing tablet comprising homogeneously mixed dry powdery materials including a quantity of anhydrous alkali metal hydroxide in quantity in excess of that reactive with all the remaining ingredients of the tablet and in quantity to generate heat for effectin the test,
water-soluble cupric salt, acidic material neutralizable by a portion of said hydroxide to form upon dissolution of the tablet a dissolved reducible cupric compound, and an effervescent couple consisting of water-soluble solid acid and of watersoluble salt of carbonic acid, said tablet being adapted to be placed in a liquid specimen to be tested for reducing sugar, which specimen may contain an ingredient tending to deposit upon and retard dissolution of the tablet, said couple functioning to generate gas and break up the tablet while the material of the tablet is dissolving in said liquid specimen and is raising the temperature of said specimen to effect said test by forming cuprous oxide, the generation of gas avoiding exercise of any tendency of any ingredient of the specimen to deposit upon any mass of the tablet and retard its dissolution, whereby the dissolution is hastened and the attained temperature is higher by avoiding loss of heat through shorter time for dissolution.
3. A normally self-sustaining heat-generating compressed sugar-testing tablet comprising homogeneously mixed dry powdery materials including a quantity of anhydrous alkali metal hydroxide in quantity in excess of that reactive with all the remaining ingredients of the tablet and in quantity to generate heat for effecting the test, watersoluble cupric salt, solubilizing agent selected from the group consisting of tartaric acid, citric acid, and their alkali metal salts for dissolving the reaction product of said cupric salt and said alkali metal hydroxide for supplying to the specimen a dissolved reducible cupric compound, and an effervescent couple consisting of water-soluble solid acid and of water-soluble salt of carbonic acid, said tablet being adapted to be placed in a liquid specimen to be tested for reducing sugar, which specimen may contain an ingredient tending to deposit upon and retard dissolution of the tablet, said couple functioning to generate gas and break up the tablet while the material of the tablet is dissolving in said liquid specimen and is raising the temperature of said specimen to eifect said test by forming cuprous oxide, the generation of gas avoiding exercise of any tendency of any ingredient of the specimen to deposit .upon any mass of the tablet and retard its dissolution, whereby the dissolution is hastened and the attained temperature is higher by avoiding loss of heat through shorter time for dissolution.
4. A testing tablet adapted for dissolution in an aqueous liquid to be tested, which liquid may contain an ingredient tending to retard the dissolution of the tablet by deposition thereon, and adapted to supply chemical reagent material to eflect the test, said tablet comprising dry solid ingredients in uniform distribution, including a quantity of alkali metal hydroxide which is effective in the test upon dissolution of the tablet in the liquid, and further comprising an efiervescent couple consisting of solid acid and of solid salt of carbonic acid for interaction in the presence of water to generate carbon dioxide'on contact with said liquid for breaking up the tablet, the quantity of said hydroxide being greater than that which is chemically equivalent to the active acid content of said couple, whereby said carbon dioxide is formed in the presence of undissolved hydroxide to break up the tablet and hasten its dissolution, the generation of gas being also effective to agitate the liquid and to expose fresh tablet surfaces with the avoidance of possible dissolution-retarding deposition on any solid mass of the original tablet form.
5. A testing tablet adapted for dissolution in an aqueous liquid to be tested, which liquid may contain an ingredient tending to retard the dissolution of the tablet by deposition thereon, said tablet comprising dry solid ingredients in uniform distribution, including chemical reagent material to effect the test, and further comprising alkali metal hydroxide and also an effervescent couple consisting of solid acid and of solid salt of carbonic acid for interaction in the presence of water to generate carbon dioxide on contact with said liquid for breaking up the tablet, the amount of said hydroxide in the tablet bein in excess of an amount which will neutralize the acid of the said couple, whereby said carbon dioxide is formed in the presence of undissolved ingredients of the tablet to break up the tablet and hasten its dissolution, the generation of gas being also effective to agitate the liquid and to expose fresh tablet 45 surfaces with the avoidance of possible dissolution-retarding deposition on any solid mass of the original tablet form,
6. In the method of testing a liquid specimen by adding thereto a tablet supplying chemical reagent material to dissolve in the liquid to perform a test and alkalize the resulting medium, which liquid may contain an ingredient tending to retard dissolution of the tablet by deposition thereon, the step of dissolving in said liquid specimen a tablet containing in homogeneous admixture chemical reagent material for the test including an alkalizing quantity of alkali metal hydroxide, and an efiervescent couple consisting of watersoluble solid acid and water-soluble salt of carbonic acid, the amount of said hydroxide in the tablet being in excess of an amount which will neutralize the acid of the said couple, while generating carbon dioxide in the tablet in the presence of said hydroxide, and thereby breaking up the tablet and exposing fresh surfaces thereof, with the result of avoiding the exercise of any tendency of an ingredient of said specimen to retard the dissolution of the tablet.
'7. In the method of testing a liquid specimen by adding thereto a tablet supplying chemical reagent material to dissolve in the liquid to perform a test, which liquid may contain an ingredient tending to retard dissolution of the tablet by deposition thereon, the step of dissolving in said liquid specimen a tablet containing in homogeneous admixture chemical reagent material for the test
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US447706A US2387244A (en) | 1942-06-19 | 1942-06-19 | Tablet and method of dissolving same |
GB16740/42A GB575612A (en) | 1942-06-19 | 1942-11-25 | Improvements in and relating to analytical compositions in tablet form |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US447706A US2387244A (en) | 1942-06-19 | 1942-06-19 | Tablet and method of dissolving same |
Publications (1)
Publication Number | Publication Date |
---|---|
US2387244A true US2387244A (en) | 1945-10-23 |
Family
ID=23777403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US447706A Expired - Lifetime US2387244A (en) | 1942-06-19 | 1942-06-19 | Tablet and method of dissolving same |
Country Status (2)
Country | Link |
---|---|
US (1) | US2387244A (en) |
GB (1) | GB575612A (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2497057A (en) * | 1950-02-07 | Toilet bowl -gleanee | ||
US2750027A (en) * | 1951-08-21 | 1956-06-12 | Cummings Molly | Visual indicating devices for producing a color slick or patch at sea or in any waters |
US2799660A (en) * | 1954-04-15 | 1957-07-16 | Miles Lab | Blood test composition and method |
US2824842A (en) * | 1954-06-09 | 1958-02-25 | Sulkowitch Hirsh | Urine calcium test |
US2827420A (en) * | 1956-10-24 | 1958-03-18 | Irving B Wershaw | Therapeutic tablets |
US2838377A (en) * | 1950-03-09 | 1958-06-10 | Miles Lab | Blood test |
US2970945A (en) * | 1958-10-03 | 1961-02-07 | Miles Lab | Diagnostic composition |
US3063812A (en) * | 1957-04-02 | 1962-11-13 | Miles Lab | Determination of albumin in liquids |
US3120378A (en) * | 1960-02-29 | 1964-02-04 | Procter & Gamble | Bleaching, sterilizing and disinfecting tablet and method of preparation |
US3121612A (en) * | 1956-04-12 | 1964-02-18 | Miles Lab | Composition and method for determination of albumin in fluids, particularly urine |
US3131123A (en) * | 1959-03-13 | 1964-04-28 | Lab Francais De Therapeutique | Enteric tablets and manufacture thereof |
US3310382A (en) * | 1963-02-04 | 1967-03-21 | George R Kingsley | Biuret reagent |
US3676359A (en) * | 1970-10-14 | 1972-07-11 | Us Navy | Chemical sea surface marker |
US4588696A (en) * | 1983-02-17 | 1986-05-13 | Eskelson Cleamond D | Pellet process for the detection of formaldehyde and/or glutaraldehyde |
US4956300A (en) * | 1982-01-05 | 1990-09-11 | Helena Laboratories Corporation | Aid for determining the presence of occult blood, method of making the aid, and method of using the aid |
EP0396156A1 (en) | 1985-06-28 | 1990-11-07 | Miles Inc. | Method of manufacturing a membrane for an electrochemical sensor |
US5081040A (en) * | 1987-06-29 | 1992-01-14 | Helena Laboratories Corporation | Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes |
US5196167A (en) * | 1989-04-04 | 1993-03-23 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
US5217874A (en) * | 1989-04-04 | 1993-06-08 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
US5273888A (en) * | 1984-01-16 | 1993-12-28 | Helena Laboratories Corporation | Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals |
WO1996036866A1 (en) * | 1992-07-15 | 1996-11-21 | Aquarium Pharmaceuticals, Inc. | Method for determining dissolved oxygen in water |
US5702913A (en) * | 1983-12-21 | 1997-12-30 | Helena Laboratories Corporation | Chromgen-reagent test system |
US7150995B2 (en) | 2004-01-16 | 2006-12-19 | Metrika, Inc. | Methods and systems for point of care bodily fluid analysis |
US20080108130A1 (en) * | 2004-11-25 | 2008-05-08 | Takahiro Nakaminami | Sensor Device |
US7635597B2 (en) | 1995-08-09 | 2009-12-22 | Bayer Healthcare Llc | Dry reagent particle assay and device having multiple test zones and method therefor |
WO2011133911A1 (en) * | 2010-04-22 | 2011-10-27 | Amerilab Technologies, Inc. | An effervescent carrier, a method of changing the flavor of milk, and an effervescent tablet for changing the flavor of milk |
US10040524B1 (en) | 2017-04-28 | 2018-08-07 | Calvin Collins | Sustained release water marking device for search and rescue |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1054348A (en) * | 1965-10-28 | |||
US3847547A (en) * | 1972-11-24 | 1974-11-12 | France Etat | Process and apparatus for detecting of the presence of a liquid |
GB2120787B (en) * | 1982-05-26 | 1986-02-19 | Lilly Industries Ltd | Method of estimating feed additives |
-
1942
- 1942-06-19 US US447706A patent/US2387244A/en not_active Expired - Lifetime
- 1942-11-25 GB GB16740/42A patent/GB575612A/en not_active Expired
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2497057A (en) * | 1950-02-07 | Toilet bowl -gleanee | ||
US2838377A (en) * | 1950-03-09 | 1958-06-10 | Miles Lab | Blood test |
US2750027A (en) * | 1951-08-21 | 1956-06-12 | Cummings Molly | Visual indicating devices for producing a color slick or patch at sea or in any waters |
US2799660A (en) * | 1954-04-15 | 1957-07-16 | Miles Lab | Blood test composition and method |
US2824842A (en) * | 1954-06-09 | 1958-02-25 | Sulkowitch Hirsh | Urine calcium test |
US3121612A (en) * | 1956-04-12 | 1964-02-18 | Miles Lab | Composition and method for determination of albumin in fluids, particularly urine |
US2827420A (en) * | 1956-10-24 | 1958-03-18 | Irving B Wershaw | Therapeutic tablets |
US3063812A (en) * | 1957-04-02 | 1962-11-13 | Miles Lab | Determination of albumin in liquids |
US2970945A (en) * | 1958-10-03 | 1961-02-07 | Miles Lab | Diagnostic composition |
US3131123A (en) * | 1959-03-13 | 1964-04-28 | Lab Francais De Therapeutique | Enteric tablets and manufacture thereof |
US3120378A (en) * | 1960-02-29 | 1964-02-04 | Procter & Gamble | Bleaching, sterilizing and disinfecting tablet and method of preparation |
US3310382A (en) * | 1963-02-04 | 1967-03-21 | George R Kingsley | Biuret reagent |
US3676359A (en) * | 1970-10-14 | 1972-07-11 | Us Navy | Chemical sea surface marker |
US4956300A (en) * | 1982-01-05 | 1990-09-11 | Helena Laboratories Corporation | Aid for determining the presence of occult blood, method of making the aid, and method of using the aid |
US4588696A (en) * | 1983-02-17 | 1986-05-13 | Eskelson Cleamond D | Pellet process for the detection of formaldehyde and/or glutaraldehyde |
US5702913A (en) * | 1983-12-21 | 1997-12-30 | Helena Laboratories Corporation | Chromgen-reagent test system |
US5273888A (en) * | 1984-01-16 | 1993-12-28 | Helena Laboratories Corporation | Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals |
EP0396156A1 (en) | 1985-06-28 | 1990-11-07 | Miles Inc. | Method of manufacturing a membrane for an electrochemical sensor |
US5081040A (en) * | 1987-06-29 | 1992-01-14 | Helena Laboratories Corporation | Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes |
US5217874A (en) * | 1989-04-04 | 1993-06-08 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
US5196167A (en) * | 1989-04-04 | 1993-03-23 | Helena Laboratories Corporation | Fecal occult blood test product with positive and negative controls |
WO1996036866A1 (en) * | 1992-07-15 | 1996-11-21 | Aquarium Pharmaceuticals, Inc. | Method for determining dissolved oxygen in water |
US7635597B2 (en) | 1995-08-09 | 2009-12-22 | Bayer Healthcare Llc | Dry reagent particle assay and device having multiple test zones and method therefor |
US7150995B2 (en) | 2004-01-16 | 2006-12-19 | Metrika, Inc. | Methods and systems for point of care bodily fluid analysis |
US20080108130A1 (en) * | 2004-11-25 | 2008-05-08 | Takahiro Nakaminami | Sensor Device |
WO2011133911A1 (en) * | 2010-04-22 | 2011-10-27 | Amerilab Technologies, Inc. | An effervescent carrier, a method of changing the flavor of milk, and an effervescent tablet for changing the flavor of milk |
US10040524B1 (en) | 2017-04-28 | 2018-08-07 | Calvin Collins | Sustained release water marking device for search and rescue |
Also Published As
Publication number | Publication date |
---|---|
GB575612A (en) | 1946-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2387244A (en) | Tablet and method of dissolving same | |
Millonig | A modified procedure for lead staining of thin sections | |
US4839295A (en) | Measurement of protein using bicinchoninic acid | |
US3309324A (en) | Corrosion inhibited ammonium sulfate solutions and compositions useful for manufacturing them | |
US2497057A (en) | Toilet bowl -gleanee | |
US3256203A (en) | Cooling water treatment and compositions useful therein | |
US6136768A (en) | Drain cleaner | |
US4013820A (en) | Universally useable tableting ingredients | |
US5567389A (en) | Method for controlled dispensing of extended-release chemical formulation in tablet form | |
US3240708A (en) | Corrosion inhibitor compositions | |
US2649398A (en) | Douche composition | |
ES419152A1 (en) | Bleaching agent | |
US4395344A (en) | Drain opener composition | |
US5876707A (en) | Extended-release chemical formulation in tablet form for urine pretreatment | |
US3663271A (en) | Surface-modified acid crystals and process for their preparation | |
US2313523A (en) | Photographic material | |
Beard | Experimental observations on coagulation of insect hemolymph | |
US5660821A (en) | Extended-release chemical formulation in tablet form for urine pretreatment | |
US1599996A (en) | Cleaning compound and process of preventing the deliquescence of a salt | |
US2418033A (en) | Diagnostic compositions | |
US5008029A (en) | Delayed action drain cleaner compositions | |
US1486002A (en) | Process for the production of water-soluble durable preparations containing acetyl-salicylic acid | |
US1557266A (en) | Composition adapted to generate free iodine | |
Howell | Alkalinity of non-industrial cleaning products and the likelihood of producing significant esophageal burns | |
US6093387A (en) | Extended-release chemical formulation in tablet form for urine pretreatment |